| scholarly article | Q13442814 |
| P50 | author | Mark A. Lemmon | Q24076870 |
| P2093 | author name string | K M Ferguson | |
| T L Macatee | |||
| M J Mohan | |||
| P J Darling | |||
| P2860 | cites work | Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase | Q22009917 |
| Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin | Q24305421 | ||
| Binding of Neu Differentiation Factor with the Extracellular Domain of Her2 and Her3 | Q24315647 | ||
| HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers | Q24336345 | ||
| Identification of heregulin, a specific activator of p185erbB2 | Q24338146 | ||
| SH2 domains recognize specific phosphopeptide sequences | Q27860748 | ||
| Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2 | Q28279061 | ||
| The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 | Q28513922 | ||
| ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation | Q28594099 | ||
| The cellular response to neuregulins is governed by complex interactions of the erbB receptor family | Q28609130 | ||
| Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function | Q28678683 | ||
| ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer | Q28678776 | ||
| Growth factor signaling by receptor tyrosine kinases | Q29618315 | ||
| SH2/SH3 signaling proteins | Q30194539 | ||
| An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors | Q30463969 | ||
| Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). | Q33730975 | ||
| Two EGF molecules contribute additively to stabilization of the EGFR dimer | Q33885990 | ||
| ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling | Q33886341 | ||
| Bivalence of EGF-like ligands drives the ErbB signaling network | Q33887274 | ||
| Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor | Q34180911 | ||
| Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 | ||
| Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation | Q35054357 | ||
| EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions | Q35980208 | ||
| Interaction between proteins localized in membranes | Q37396417 | ||
| Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain | Q38334256 | ||
| Epidermal growth factor binding induces a conformational change in the external domain of its receptor | Q38342722 | ||
| Local aggregation of hormone–receptor complexes is required for activation by epidermal growth factor | Q40226398 | ||
| Dimerization of cell surface receptors in signal transduction | Q40579106 | ||
| Regulation of signal transduction and signal diversity by receptor oligomerization | Q40592846 | ||
| A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling | Q40673334 | ||
| Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4. | Q41020913 | ||
| Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3 | Q41107277 | ||
| The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant | Q41438473 | ||
| The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions | Q41554100 | ||
| The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex | Q41710005 | ||
| Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation | Q41710300 | ||
| Specificity within the EGF family/ErbB receptor family signaling network | Q41721612 | ||
| Autoregulatory mechanisms in protein-tyrosine kinases | Q41758716 | ||
| Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells | Q42025518 | ||
| Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction | Q42141978 | ||
| Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation | Q42814150 | ||
| Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses | Q42819990 | ||
| EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. | Q52444456 | ||
| Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins | Q68139662 | ||
| Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation | Q68818445 | ||
| Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation | Q72871521 | ||
| Secondary dimerization between members of the epidermal growth factor receptor family | Q73257880 | ||
| Binding specificities and affinities of egf domains for ErbB receptors | Q77360929 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4632-4643 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Extracellular domains drive homo- but not hetero-dimerization of erbB receptors | |
| P478 | volume | 19 |
| Q39552974 | A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth. |
| Q34587922 | A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions |
| Q28207289 | An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors |
| Q28278895 | Argos inhibits epidermal growth factor receptor signalling by ligand sequestration |
| Q38885404 | Blockade of a key region in the extracellular domain inhibits HER2 dimerization and signaling. |
| Q35026889 | Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase. |
| Q27860474 | Cell signaling by receptor tyrosine kinases |
| Q34625617 | Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor |
| Q36537873 | Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies |
| Q43993786 | Disabling receptor ensembles with rationally designed interface peptidomimetics |
| Q37204361 | Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling |
| Q30524738 | Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells |
| Q24296900 | EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization |
| Q42081733 | EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms. |
| Q47680913 | EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics |
| Q43238274 | EGFR mutations cause a lethal syndrome of epithelial dysfunction with progeroid features |
| Q44517519 | Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment |
| Q35699603 | Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition |
| Q59127611 | EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers |
| Q40816275 | Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. |
| Q24529941 | Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface |
| Q34583143 | ErbB-4: a receptor tyrosine kinase |
| Q27657234 | ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor |
| Q38989275 | Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery |
| Q33276402 | GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. |
| Q42088721 | Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family |
| Q64226685 | Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells |
| Q64079004 | Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations |
| Q24297029 | Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association |
| Q39839427 | In vitro enzymatic characterization of near full length EGFR in activated and inhibited states |
| Q39744916 | In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore |
| Q34314489 | Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex |
| Q37320814 | Interaction of antibodies with ErbB receptor extracellular regions |
| Q40756590 | Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides |
| Q35733874 | Ligand regulation of a constitutively dimeric EGF receptor |
| Q37154122 | Ligand-induced ErbB receptor dimerization |
| Q38118370 | Links between Schwann cells and melanocytes in development and disease. |
| Q27650259 | Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization |
| Q24310089 | Mechanism of activation and inhibition of the HER4/ErbB4 kinase |
| Q37652898 | Molecular determinants of KA1 domain-mediated autoinhibition and phospholipid activation of MARK1 kinase |
| Q40316579 | Molecular modeling of nearly full-length ErbB2 receptor. |
| Q36090263 | N-cadherin enhances APP dimerization at the extracellular domain and modulates Aβ production |
| Q50876579 | Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide. |
| Q39089524 | Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors |
| Q38327516 | Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation |
| Q34249105 | Populations of radial glial cells respond differently to reelin and neuregulin1 in a ferret model of cortical dysplasia |
| Q40657210 | Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels |
| Q28214910 | RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6 |
| Q73046119 | Ready to partner |
| Q35234339 | Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation |
| Q30884331 | Selective formation of ErbB-2/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands |
| Q27678732 | Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains |
| Q37197992 | Structure-based view of epidermal growth factor receptor regulation |
| Q39085589 | Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein. |
| Q34464911 | Survey of the year 2000 commercial optical biosensor literature |
| Q37035553 | Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells |
| Q38201344 | The EGFR family: not so prototypical receptor tyrosine kinases |
| Q27640631 | The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors |
| Q36268324 | The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it? |
| Q24536067 | The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand |
| Q35883970 | The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling. |
| Q43821697 | The single transmembrane domains of ErbB receptors self-associate in cell membranes |
| Q37704902 | Transmembrane helix-helix interactions involved in ErbB receptor signaling. |
| Q38344359 | Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization |
| Q27860884 | Untangling the ErbB signalling network |
| Q43748137 | Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation |
| Q64238188 | Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging |
| Q37643945 | erbB3 is an active tyrosine kinase capable of homo- and heterointeractions |
Search more.